Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PATIENTS WITH UPPER EXTREMITY SURGERY”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Early research (Phase 1)Looking for participantsNCT07676890
What this trial is testing

A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After Surgery

Who this might be right for
Ovarian CancermRNA Vaccine
West China Hospital 9
Testing effectiveness (Phase 2)Looking for participantsNCT06354218
What this trial is testing

Serplulimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Who this might be right for
Esophageal Carcinoma
The First Affiliated Hospital with Nanjing Medical University 50
Testing effectiveness (Phase 2)Ended earlyNCT02481960
What this trial is testing

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

Who this might be right for
Glioma
Boston Scientific Corporation 5
Testing effectiveness (Phase 2)WithdrawnNCT05178576
What this trial is testing

A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy

Who this might be right for
Colon Cancer
NSABP Foundation Inc
Not applicableUnknownNCT03722875
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 45
Not applicableStudy completedNCT03009890
What this trial is testing

Surgery vs. Casting for Displaced Articular Radius Fractures in Elderly

Who this might be right for
Radius Distal Fracture
JointResearch 138
Large-scale testing (Phase 3)Study completedNCT00112918
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 3,451
Testing effectiveness (Phase 2)Study completedNCT03322267
What this trial is testing

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

Who this might be right for
Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 26
Not applicableStudy completedNCT04773106
What this trial is testing

Long-term Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Underwent Non-penetrating Glaucoma Surgery

Who this might be right for
GlaucomaOpen Angle Glaucoma
Implandata Ophthalmic Products GmbH 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT02989584
What this trial is testing

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)UnknownNCT04974827
What this trial is testing

Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
Hunan Cancer Hospital 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965468
What this trial is testing

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

Who this might be right for
Non-small Cell Lung CancerStage IVOligometastasis
ETOP IBCSG Partners Foundation 96
Not applicableLooking for participantsNCT06496659
What this trial is testing

Segmentectomy After Induction Therapy (SAINT)

Who this might be right for
Segmentectomy
Northwestern University 25
Large-scale testing (Phase 3)Study completedNCT01219881
What this trial is testing

Comparing Desflurane to Sevoflurane for the Effect on Recovery Time in Patients Undergoing Urological Cystoscope Surgery

Who this might be right for
CystoscopesBaxter Anaesthesia Brand of DesfluraneSevoflurane
Ohio State University 75
Testing effectiveness (Phase 2)Study completedNCT02965976
What this trial is testing

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Roswell Park Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT00331838
What this trial is testing

Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery

Who this might be right for
Venous Thromboembolism
Sanofi 705
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07522411
What this trial is testing

Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
BinYong Liang 100
Not applicableUnknownNCT05523050
What this trial is testing

Active Surgical Intervention on Crohn's Disease

Who this might be right for
Crohn Disease
Wuxi People's Hospital 100
Not applicableNot Yet RecruitingNCT07699172
What this trial is testing

EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors

Who this might be right for
GliomaBrain NeoplasmBrain Tumor Adult
Bo Wang 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284
What this trial is testing

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Rutgers, The State University of New Jersey 90
Next Page